Cantor Fitzgerald raises Coinbase stock price target on product outlook

Cantor Fitzgerald raised its Coinbase price target to $250 from $221 and kept an Overweight rating ahead of first-quarter fiscal 2026 earnings on May 7. The firm said investors are focused less on backward-looking results and more on crypto price stability, regulatory updates, forward demand trends, and Coinbase’s product roadmap, especially its prediction markets business. Offset by Barclays’ downgrade to Underweight and a cut in price target to $140, the overall setup is mixed but slightly constructive for COIN.

Analysis

The market is no longer pricing COIN like a pure beta proxy; it is starting to value it as a derivatives-on-crypto liquidity platform where product mix and regulatory optionality matter more than spot prices. That shift matters because earnings pressure from weak trading volumes is a lagging indicator, while the next leg of re-rating will come from whether new offerings can monetize engagement without needing a sustained crypto rally. In other words, the stock can hold up even if headline volumes stay soft, but only if management proves that non-transaction revenue can offset cycle weakness.

The underappreciated second-order effect is that a cleaner U.S. regulatory backdrop would not just help Coinbase — it would widen the gap versus offshore venues that rely more heavily on price-sensitive trading flow. If the company can convert current interest in prediction markets into sticky user behavior, it adds a new monetization vector that is less tethered to BTC/ETH volatility and may improve valuation quality over the next 2-3 quarters. That said, the current move has already priced in a meaningful amount of good news, so a modest earnings miss or cautious guidance could compress multiples quickly because the name is being owned for a forward thesis, not for current fundamentals.

Consensus appears too focused on whether Q1 volumes were weak and not enough on what level of “acceptable stagnation” the market will tolerate if management can show product-led share gains. The risk is that COIN becomes a crowded long on the belief that regulation and new products will solve cyclical weakness; if those catalysts slip, the downside is amplified because the stock has recently re-rated ahead of proof. The most interesting asymmetry is that the first sign of durable non-trading monetization could trigger a larger rerating than the market expects, but absent that, the stock likely trades as a high-beta multiple compression story over the next 1-2 months.

Key Decisions for Investors

• Sell upside volatility into earnings: use COIN call spreads or outright covered calls into the May 7 print, targeting a 2-4 week window where forward commentary matters more than results; risk/reward favors harvesting elevated premium after the recent run.
• Pair trade: long COIN / short BCS over the next 1-3 months. If crypto activity stabilizes and U.S. regulatory clarity improves, COIN has more operating leverage and product optionality, while the short leg offsets broad brokerage/market-volume weakness.
• If you want directional upside, buy COIN on a post-earnings dip only if management gives explicit metrics around non-transaction revenue or prediction markets adoption; otherwise wait for a lower entry as the stock still screens rich versus the near-term earnings setup.
• Hedge the event risk with a short-dated put spread into May 7. The left-tail is a guidance reset on trading volumes or regulatory timing, which could cut 10-15% from the stock quickly given current positioning.
• For multi-month exposure, prefer a staged long only if BTC volatility normalizes and the stock holds above the recent breakout zone; the best case is a gradual multiple expansion, but the setup does not justify aggressive size before proof of durable demand.